In the next year or so, a new mixture of drugs could be available to fight breast cancer.

The treatment is called immunotherapy, and unlike chemotherapy, the new treatment tricks the cancer into killing itself.

During a study of 1,000 women given one of the two new cocktails in a clinical trial, half were able to get their cancers under control.

Thirty percent of patients given one of those cocktails, anti PD1, which targets kidney and lung cancers, saw a decrease in tumor size.

Those given antibody drug complex, which attacks breast cancer, saw their risk of dying reduced 38 percent compared to those taking conventional drugs.

It's being called a game changer, and it's already saving lives.

The drugs will not be available until next year. But experts say patients can talk to their oncologist about whether they're eligible for clinical trials.

For more information, click here.